Chemical Structure : VCP979
货号: PC-49694Not For Human Use, Lab Use Only.
VCP979 (VCP-979) is a novel selective small molecule p38 MAPK inhibitor with a significantly greater affinity for the active form of p38 MAPK, has significant anti-fibrotic effects in vitro and in vivo.
规格 | 价格 | 库存 | 数量 |
---|
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
VCP979 (VCP-979) is a novel selective small molecule p38 MAPK inhibitor with a significantly greater affinity for the active form of p38 MAPK, has significant anti-fibrotic effects in vitro and in vivo.
VCP979 significantly promoted axonal/white matter (WM) remodeling, neural progenitor cell migration, and improved functional recovery in T2DM mice.
VCP979 improved axonal/WM remodeling and functional outcomes in a diabetic mouse stroke mode.
VCP979 effectively suppressed orthotopic pancreatic cancer growth and metastasis.
VCP979 effectively reduced renal fibrosis, extracellular matrix accumulation, and alleviated epithelial-mesenchymal transition in UUO rats.
分子量 | ||
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Cai Y, et al. J Biomed Nanotechnol. 2018 Mar 1;14(3):585-593.
2. Liu J, et al. Int J Mol Med. 2020 Feb;45(2):353-364.
3. Min S, et al. Exp Biol Med (Maywood). 2023 Jan 30:15353702221147569.
4. Natalie B Vinh, et al. ChemistryOpen. 2015 Feb;4(1):56-64.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright